Clormezanona [INN-Spanish] en es it fr

Category

Clormezanona_[INN-Spanish]
add to favotites goo dig stu tec squ mys
fac del pro twi yah mya far


Clormezanona [INN-Spanish] Brand names, Clormezanona [INN-Spanish] Analogs

Clormezanona [INN-Spanish] Brand Names Mixture

  • No information avaliable

Clormezanona [INN-Spanish] Chemical_Formula

C11H12ClNO3S

Clormezanona [INN-Spanish] RX_link

No information avaliable

Clormezanona [INN-Spanish] fda sheet

Clormezanona [INN-Spanish] msds (material safety sheet)

Clormezanona [INN-Spanish] Synthesis Reference

No information avaliable

Clormezanona [INN-Spanish] Molecular Weight

273.737 g/mol

Clormezanona [INN-Spanish] Melting Point

116.2 oC

Clormezanona [INN-Spanish] H2O Solubility

2500 mg/L (hardly soluble)

Clormezanona [INN-Spanish] State

Solid

Clormezanona [INN-Spanish] LogP

1.208

Clormezanona [INN-Spanish] Dosage Forms

No information avaliable

Clormezanona [INN-Spanish] Indication

Used in the management of anxiety and in the treatment of muscle spasm.

Clormezanona [INN-Spanish] Pharmacology

Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).

Clormezanona [INN-Spanish] Absorption

No information avaliable

Clormezanona [INN-Spanish] side effects and Toxicity

Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.

Clormezanona [INN-Spanish] Patient Information

No information avaliable

Clormezanona [INN-Spanish] Organisms Affected

Humans and other mammals